Lund University Hospital

This study tests whether adding a third chemotherapy drug (irinotecan) to the standard two-drug regimen before and after surgery can improve outcomes for people with resectable stomach or gastroesophageal junction cancer. About 60 adults with early-stage but locally advanced dise…

This study tests whether adding capecitabine to standard carboplatin-based chemotherapy before surgery can improve the chance of eliminating all cancer in the breast for people with early triple-negative breast cancer. About 325 adults with ER-negative, HER2-negative breast cance…